![Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. | Semantic Scholar Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5dd1c1030ee5cf96844d0c88cbb93e460d1e5540/4-Figure1-1.png)
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. | Semantic Scholar
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica
![Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience. - ScienceDirect Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience. - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213048921000510-gr1.jpg)
Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience. - ScienceDirect
![Frontiers | Case report: Successful management of a refractory double- expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test Frontiers | Case report: Successful management of a refractory double- expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test](https://www.frontiersin.org/files/Articles/1079890/fonc-12-1079890-HTML/image_m/fonc-12-1079890-g001.jpg)
Frontiers | Case report: Successful management of a refractory double- expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test
![Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021 Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021](https://journals.sagepub.com/cms/10.1177/20406207211013987/asset/images/large/10.1177_20406207211013987-fig3.jpeg)
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica
![Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram](https://www.researchgate.net/publication/282046248/figure/fig1/AS:499557352079360@1496115162692/Kaplan-Meier-curves-of-progression-free-survival-and-overall-survival-Progression-free.png)
Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram
![Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13000-019-0856-7/MediaObjects/13000_2019_856_Fig2_HTML.png)
Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text
![Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13000-019-0856-7/MediaObjects/13000_2019_856_Fig3_HTML.png)
Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text
![Impact of Cell of Origin Classification on Survival Outcomes after Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation Impact of Cell of Origin Classification on Survival Outcomes after Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation](https://www.astctjournal.org/cms/asset/61020c05-9fa0-4acb-aac1-29bafcf15986/gr1.jpg)
Impact of Cell of Origin Classification on Survival Outcomes after Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation
![Progression-free survival (PFS) curves (A) and overall survival (OS)... | Download Scientific Diagram Progression-free survival (PFS) curves (A) and overall survival (OS)... | Download Scientific Diagram](https://www.researchgate.net/publication/301288967/figure/fig2/AS:499556519342080@1496114963286/Progression-free-survival-PFS-curves-A-and-overall-survival-OS-curves-B-of-the.png)
Progression-free survival (PFS) curves (A) and overall survival (OS)... | Download Scientific Diagram
![Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas - The Lancet Oncology Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas - The Lancet Oncology](https://www.thelancet.com/cms/attachment/833f0a17-a9f5-4ef4-bba9-b5f3ef6e3b3b/gr2_lrg.jpg)
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas - The Lancet Oncology
![Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/2119035701/2088332348/ybbmt54880-fig-0001.jpg)
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation
![Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. | Semantic Scholar Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/be97aebbcd2be272d04201fac48ca772d19398c5/9-Figure3-1.png)
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. | Semantic Scholar
![Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | Indian Journal of Hematology and Blood Transfusion Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | Indian Journal of Hematology and Blood Transfusion](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12288-019-01248-w/MediaObjects/12288_2019_1248_Fig3_HTML.png)
Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | Indian Journal of Hematology and Blood Transfusion
![Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-018-0320-9/MediaObjects/41375_2018_320_Fig1_HTML.png)
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia
![Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. | Semantic Scholar Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/be97aebbcd2be272d04201fac48ca772d19398c5/7-Figure2-1.png)